Report #2850589

Received Jul 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 9 yrs
State: TX
Recovered: Unknown
Vaccinated: Jun 25, 2025
Onset: Jun 25, 2025
Days to onset: 0
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MMRV	MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)	MERCK & CO. INC.	UNK	X027626	OT
MMRV	MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)	MERCK & CO. INC.	UNK	—	OT

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

no additional AE; expired dose of PROQUAD was administered to a 9 year old, female patient; This spontaneous report was received from the Office Manager and refers to a 9-year-old female patient. Her medical history, concurrent conditions and concomitant therapies were not reported. On 25-Jun-2025, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #X027626, expiration date: 28-May-2025) 0.5 mL (reported as .5 ml), administered by unknown route as prophylaxis (Expired product administered). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (no details provided). No additional adverse events (AE). At the reporting time, the outcome of the events was unknown. The action taken with the suspect products was not applicable.